Broadbent tapped as Xcellerex CEO

Guy Broadbent has been appointed president and CEO of Xcellerex and a member of the company's board of directors. Release

Affymax names John Orwin president and COO. Release

Bristol-Myers Squibb board elects Charles Bancroft CFO. Release

FORMA Therapeutics has announced that Robert Forrester has been appointed COO. Release

Somaxon Pharmaceuticals has appointed Tran Nguyen as VP and CFO. Release

KV Pharmaceutical has announced it has appointed Stephen Stamp as CFO and treasurer. Release

Luca Santarelli has been named head of the Central Nervous System (CNS) Discovery and Translational Area at Roche. Release

Dipak Panigrahi will join QLT as SVP, R&D and chief medical officer. Release

Inspire Pharmaceuticals will name Andrew Koven to the newly created position of EVP and chief administrative and legal officer, effective May 10, 2010. Release

Suggested Articles

Preclinical-stage biotech Abpro Therapeutics wants to trial its two lead candidates for HER2-positive cancers and diabetic macular edema in 2019.

After a rough patch in 2017, the stars seem to be realigning for French CAR-T expert Cellectis, which just closed a $164 million U.S. public offering.

Investment firm Frazier Healthcare Partners has closed its 11th fund—worth $780 million—that will help established companies accelerate their growth.